Adult presentation of MCAD deficiency revealed by coma and severe arrythmias.
- 307 Downloads
We report the case of a 33-year-old man who presented with headaches and vomiting. Soon after admission he became drowsy and agitated, developed ventricular tachycardia and his neurological state worsened (Glasgow coma score 6). Blood analysis showed respiratory alkalosis, hyperlactacidemia (8 mmol/l), hyperammonemia (390 µmol/l) and hypoglycaemia (2.4 mmol/l). Subsequently, he developed supraventricular tachycardia, ventricular tachycardia and ultimately ventricular fibrillation resulting in cardiac arrest, which was successfully treated. A CT scan of the head revealed cerebral oedema. Whilst in the intensive care unit, he developed renal failure and rhabdomyolysis. The metabolic abnormalities seen at the time of admission normalised within 48 h with IV glucose infusion. Biological investigations, including urinary organic acids and plasma acylcarnitines, showed results compatible with MCAD deficiency. Mutation analysis revealed the patient was homozygous for the classical mutation A985G. This is one of only a few reports of severe cardiac arrhythmia in an adult due to MCAD deficiency. This condition is probably under-diagnosed in adult patients with acute neurological and/or cardiac presentations.
KeywordsArrhythmia Coma Hypoglycaemia Hyperammonemia, Medium-chain acyl-CoA dehydrogenase deficiency Adult
- 1.Roe CR, Ding J (2001) Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly W, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 2297–2326Google Scholar
- 2.Tanaka K, Gregersen N, Ribes A Kim J, Kolvraa S, Winter V, Eiberg H, Martinez G, Deufel T, Leifert B, Santer R, Francois B, Pronicka E, Laszlo A, Kmoch S, Kremensky I, Kalaydjicva L, Ozalp I, Ito M (1997) A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey and Japan for the G985 variant allele with haplotype analysis at the medium-chain acyl-CoA dehydrogenase gene locus: clinical and evolutionary considerations. Pediatr Res 41:201–209PubMedGoogle Scholar
- 3.Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, Yoon H, Madsen JA, Reyes-Mugica M, Rinaldo P (1998) Retrospective biochemical screening of fatty acid oxidation disorders in postmortem liver of 418 cases of sudden unexpected death in the first year of life. J Pediatr 132:924–933PubMedGoogle Scholar
- 15.Yudkoff M, Daikhin Y, Nissim I, Lazarow A, Nissim I (2001) Ketogenic diet, amino acid metabolism, and seizure control. J Neurosci Res. 66:931–940Google Scholar
- 16.Saudubray JM, Ogier de Baulny H, Charpentier C (2000) Clinical approach to inherited metabolic diseases. In: Fernandes J, Saudubray JM, van den Berghe G (eds) Inborn metabolic diseases. Diagnosis and treatment. Springer-Verlag Berlin Heidelberg New York, pp 3–41Google Scholar
- 18.Carpenter K, Wiley V, Sim KG, Heath D, Wilken B (2001) Evaluation of newborn screening for medium-chain acyl-CoA dehydrogenase deficiency in 275,000 babies. Arch Dis Child (Fetal Neonatal Ed) 85:105–109Google Scholar